Medscape is available in 5 Language Editions – Choose your Edition here.



  • Author: Cory Wilczynski, MD; Chief Editor: Eric B Staros, MD  more...
Updated: Feb 12, 2014

Reference Range

Haptoglobin is an acute-phase reactant whose principal clinical utility is in defining conditions of hemolysis. levels can also become elevated in infection and inflammation.

The reference range of haptoglobin in adults is 30-200 mg/dL.[5]

In neonates, haptoglobin is absent.

Adult levels are reached by age 4 months.



Haptoglobin is used as an acute-phase marker of red blood cell (RBC) destruction. Its value decreases and may even be absent when RBCs are destroyed at twice the normal rate.

Haptoglobin values above 40 mg/dL are used to show signs of successful splenectomy. A value above 40 mg/dL is also used as an indicator in chronic hemolysis to show that splenectomy is not indicated.[1]

Increased haptoglobin levels are seen in the following conditions:[1, 2]

  • Diseases associated with elevated erythrocyte sedimentation rate (ESR) (acute-phase reactants) such as infection, trauma, inflammation, hepatitis, amyloidosis, collagen diseases, or lymphoma and leukemia
  • Obstructive or biliary diseases
  • Steroid use
  • Diabetes mellitus
  • Smoking
  • Increased estrogen level

Decreased or absent haptoglobin levels are seen in the following conditions:[1, 2]


Collection and Panels

Specimen: Plasma Condition: Fasting preferred

Container: Plasma separator tube or serum separator tube; also acceptable: green (sodium, lithium, or heparin), lavender (EDTA), or pink (K2 EDTA) tube

Collection method: Routine venipuncture

Processing: Allow specimen to clot completely at room temperature. Separate sample from plasma or serum within 2 hours of collection. Minimum required sample is around 0.5 mL. Results are typically reported within 24 hours.

Unacceptable conditions: Hemolyzed

Storage: Refrigerated

Length of storage: Ambient, refrigerated, or frozen is 3 months




Haptoglobin is a colorless protein of the alpha-globulin fraction of human serum. It transports “freed” hemoglobin released from destroyed red blood cells to the reticuloendothelial system.

Haptoglobin is produced by the liver and collects the hemoglobin from destroyed red blood cells, then transporting it back to the liver, where heme is converted to bilirubin.[1] In the setting of increased RBC destruction, haptoglobin becomes depleted, and the free hemoglobin dimmers are filtered by the kidney, ultimately producing hemosiderin.[2] Macrophages destroy the hemoglobin-haptoglobin complex.[3] The hemoglobin-haptoglobin complex is removed from the bloodstream within minutes.[4]

The kidneys can filter about 5 g of hemoglobin per day; the unprocessed and unbound hemoglobin is oxidized and then becomes methemoglobin.[2] Unbound haptoglobin has a half-life of 5 days in the serum.[4]

Haptoglobin does not reach adult values in the serum until around age 4 months.

The 3 phenotypes of haptoglobin include haptoglobin 1-1 (Hpl 1-1), haptoglobin 2-1 (Hpl 2-1), and haptoglobin 2-2 (Hpl 2-2). No diseases are associated with specific variations, but there are genetic familiarities that make the genotyping useful in paternity testing and forensic medicine.[2]


Haptoglobin is an acute-phase reactant whose principal clinical utility is in defining conditions of hemolysis. levels can also become elevated in infection and inflammation.

In hemolytic anemia, lactic dehydrogenase (LDH) levels typically increase while haptoglobin levels decrease. In a retrospective study from 1980, the sensitivity and specificity of haptoglobin in the diagnosis of hemolytic anemia was 83% and 96%, respectively. Overall, a serum haptoglobin level below 25 mg/dL equated to an 87% probability of predicting hemolytic disease.[6]

False-positive and false-negative results can occur in patients with comorbid conditions; for example hypersplenism plus hemolytic anemia may result in a false-normal overall serum value.

Other tests used in combination with haptoglobin to confirm hemolysis include peripheral smear, LDH, indirect bilirubin, reticulocyte count, complete blood count, and Coomb’s test.

Contributor Information and Disclosures

Cory Wilczynski, MD Fellow, Department of Endocrinology, Loyola Medical Center

Disclosure: Nothing to disclose.

Chief Editor

Eric B Staros, MD Associate Professor of Pathology, St Louis University School of Medicine; Director of Clinical Laboratories, Director of Cytopathology, Department of Pathology, St Louis University Hospital

Eric B Staros, MD is a member of the following medical societies: American Medical Association, American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology

Disclosure: Nothing to disclose.

  1. Wallach, J. B. (2005). Interpretation of diagnostic tests. (8 ed., p. 422). Philadelphia, PA: Lippincott Williams & Wilkins.:

  2. McClatchey, K. D. (2002). The Plasma Proteins. Clinical laboratory medicine. (2nd ed., p. 272). Philadelphia: Lippincott Wiliams & Wilkins.:

  3. Crichton, R. R. (2009). Cellular Iron Uptake and Export in Mammals. Iron metabolism: from molecular mechanisms to clinical consequences. (3rd ed., p. 171). Chichester, UK: John Wiley & Sons:

  4. Mazza, J. (2002). Hemolytic Anemia: Hereditary and Acquired. Manual of clinical hematology. (3rd ed., p. 95). Philadelphia: Lippincott Williams & Wilkins:

  5. Haptoglobin: ARUP Lab Tests. ARUP Laboratories: National Reference Laboratories. 2006-2012. Available at

  6. Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA. 1980 May 16. 243(19):1909-11. [Medline].

Plasma separator tube or serum separator tube.
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.